Loading…
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Tender Value
₹5 Cr
EMD Value
₹10.1 L
Closing Date
18 Nov 2025, 2:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
MD, AMSCL
AMSCL
Essential Drugs
2025_HFWD_47226_1
Group 1
Open Tender
Medicines
Supply
60 days
AMSCL
Please refer Tender documents.
2 documents required · 2 mandatory
₹2,000
₹10.1 L
Yes
2 Sept 2025
2 Sept 2025
18 Nov 2025
2 Sept 2025
18 Nov 2025
2 Sept 2025
Isoflurane Inhalation, 100 ml Bottle
Ketamine Injection 10 mg/ml, 10 ml Vial
Propofol Injection 10 mg/ml, 20 ml Amp
Sevoflurane Inhalation, 250 ml Bottle
Bupivacaine Injection 0.5% with 7.5% glucose, 4 ml Amp
Lignocaine Injection 2%, 30 ml Vial
Lignocaine Jelly 2%, 30 gm Tube
Lignocaine (A) + Adrenaline (B) Injection 2% (A) + 1:200000 (5 mcg/ml) (B), 30 ml Vial
Atropine Injection 0.6 mg/ml, 1 ml Amp
Glycopyrrolate Injection 0.2 mg/ml, 1 ml amp
Midazolam Injection 5 mg/ml, 1 ml amp
Atracurium Injection 10 mg/ml, 5 ml Amp
Succinylcholine Injection 50 mg/ml, 10 ml Vial
Thiocolchicoside Tablet 4 mg, 1x10
Tizanidine Tablet 2mg , 1x10
Vecuronium Powder for Injection 4 mg , Vial
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.42 MB
tender1.pdf
Tender Documents • 3.16 MB
BOQ_75348.xls
BOQ • 0.40 MB
17ExtenGP.pdf
PDF • 0.65 MB
16eXT.pdf
PDF • 0.66 MB
15ExtenGp.pdf
PDF • 0.30 MB
14extenPrebid3.pdf
PDF • 0.45 MB
13ExtensionGP1to15.pdf
PDF • 0.41 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .